Αποτελέσματα Αναζήτησης
Family members of people with T1D Call 352-294-5760 to get screened. Diagnosed with type 1 diabetes in the last year?
- About TrialNet
TrialNet is an international consortium of centers dedicated...
- Research
At the UF Diabetes Institute, research is one of our core...
- Our Staff
TrailNet at UF investigators devote time and expertise to...
- Contact Us
For General Inquiries please call 352-294-5760 If you are...
- Our Affiliates
TrialNet at UF is proud to partner with outstanding clinics...
- Screening Studies
The Pathway to Prevention screening is the first step for...
- Prevention Studies
Hydroxychloroquine Prevention Study Anti-CD3 (Teplizumab)...
- New T1D Onset and Established T1D Studies
TrialNet is testing ways to slow the progression of type 1...
- About TrialNet
TrialNet is testing rituximab-pvvr and abatacept in people (ages 8-45) who were newly diagnosed with type 1 diabetes (T1D) to learn if using both treatments, one after the other, maintains the body’s ability to make insulin.
Type 1 Diabetes TrialNet is an NIH-sponsored clinical trials network of researchers dedicated to the study, prevention, and early treatment of type 1 diabetes. Currently, there are 18 Clinical Centers in the US, including at the University of Florida, and over 200 affiliate sites.
©2023 Type 1 Diabetes TrailNet. All rights reserved.
Just fill out the brief form below, and a TrialNet representative will contact you. Or you can also contact TrialNet at 1.800.425.8361, Monday through Friday, 8a.m. to 5p.m. Eastern Time.
TrialNet is an international consortium of centers dedicated to the study, prevention, and early detection and treatment of type 1 diabetes. Researchers are part of a larger network called Type 1 Diabetes TrialNet.
Please enter your email address and password below for TrialNet and click "Sign In". If you are having trouble logging in, please email TrialNet_CRAs@epi.usf.edu. Forgot your password?
